Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Neoplasms 7Breast Neoplasms 4Lung Neoplasms 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Colorectal Neoplasms 2Uveal Melanoma 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Substance-Related Disorders 1Smoking 1Patient Acceptance of Health Care 1Motor Activity 1Lymphoma 1Lung Cancer Screening 1Leukemia 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Depression 1Death 1Central Nervous System Neoplasms 1Carcinoma, Transitional Cell 1Cancer Patients 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 88Carboplatin 77Specimen Handling 76Magnetic Resonance Spectroscopy 63Pemetrexed 59Cisplatin 47durvalumab 44Paclitaxel 38Nivolumab 34atezolizumab 32osimertinib 29Radiotherapy 29Radiosurgery 29Biopsy 26Blood Specimen Collection 25Gemcitabine 24Docetaxel 24Immunoglobulin G 23Disulfides 22Standard of Care 21Drug Therapy 21Etoposide 19Taxes 18Practice Guidelines as Topic 18Radiation 17Educational Status 16130-nm albumin-bound paclitaxel 15X-Rays 14Surveys and Questionnaires 14Bevacizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lung Neoplasms × Focus Groups × 1 year × Clear all
NCT07382557 2026-02-03

Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System

M.D. Anderson Cancer Center

Phase NA Recruiting
360 enrolled
Thoracic

Lung Neoplasms

NCT05833334 2026-01-30

HHS

Dartmouth-Hitchcock Medical Center

Phase NA Recruiting
172 enrolled
Thoracic

Lung Neoplasms, Smoking

NCT06432985 2025-09-30

CM_TUD_Cancer

VA Office of Research and Development

Phase NA Recruiting
108 enrolled
Thoracic

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡